Laboratory of Clinical Oncology

How do you participate in the implementation of the “from bench to bed” principle?

As a link between basic and clinical science, Clinical Oncology laboratory aims to accelerate our ability to translate findings made in basic research into real applications at patient‘s bedside.

Staff of Laboratory includes representatives from different clinical departments and their task is to collaborate with scientists in order to improve Cancer diagnostics, treatment and Cancer care services. Works are going towards research and investigation of biomarkers in different cancer sites, different radiation treatment/fractionation modalities, combined treatment (surgery/radiation/medical oncology) variations, effects of treatment response evaluated by MRI, CT and SPECT-CT scanners, tumor/cells radiosensitivity investigation, possible implication of immunotherapy and other methods in order to apply personalised treatment strategy to each patient.

  1. Perspective observation cohortive clinical trial to define resectal length in colon Cancer (2016-2018, Head PI-A. Dulskas).
  2. Molecular tools for long term prostate cancer follow-up and treatment individualisation (2016-2018, Head PI- F. Jankevicius).
  3. Analysis of non -small cell lung cancer immune microenvironment and its prognostic and predictive value (2016-2020, Head PI-S.Cicenas).
  4. Perspective analysis of malignant gliomas multiparametric MRI biomarkers and response to the treatment (2014-2019, Head PI-E.Aleknavicius).


  1. Aarestrup FM, Albeyatti A, Armitage WJ, Auffray C, Augello L, Balling R, Benhabiles N, Bertolini G, Bjaalie JG, Black M, Blomberg N, Bogaert P, Bubak M, Claerhout B, Clarke L, De Meulder B, D'Errico G, Di Meglio A, Forgo N, Gans-Combe C, Gray AE, Gut I, Gyllenberg A, Hemmrich-Stanisak G, Hjorth L, Ioannidis Y, Jarmalaite S, Kel A, Kherif F, Korbel JO, Larue C, Laszlo M, Maas A, Magalhaes L, Manneh-Vangramberen I, Morley-Fletcher E, Ohmann C, Oksvold P, Oxtoby NP, Perseil I, Pezoulas V, Riess O, Riper H, Roca J, Rosenstiel P, Sabatier P, Sanz F, Tayeb M, Thomassen G, Van Bussel J, Van den Bulcke M, Van Oyen H. Towards a European health research and innovation cloud (HRIC). Genome Med. 2020 Feb 19;12(1):18. doi: 10.1186/s13073-020-0713-z.
  2. Stuopelyte K, Sabaliauskaite R, Bakavicius A, Haflidadóttir BS, Visakorpi T, Väänänen RM, Patel C, Danila DC, Lilja H, Lazutka JR, Ulys A, Jankevicius F, Jarmalaite S. Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate. J Urol. 2020 Feb 18:101097JU0000000000000803. doi: 10.1097/JU.0000000000000803.
  3. Bakavičius A, Drevinskaitė M, Daniūnaitė K, Barisienė M, Jarmalaitė S, Jankevičius F. The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival. Medicina (Kaunas). 2020 Feb 4;56(2). doi: 10.3390/medicina56020061.


  1. Dulskas A, Bandar AM, Choi YY, Shin SJ, Beom SH, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH. A case of gastric cancer metastasis to the breast in a female with BRCA2 germline mutation and literature review. Acta Chir Belg. 2019 Feb;119(1):59-63. doi: 10.1080/00015458.2017.1411554. (IF=0,521)
  2. Bausys A, Kuliavas J, Dulskas A, Kryzauskas M, Pauza K, Kilius A, Rudinskaite G, Sangaila E, Bausys R, Stratilatovas E. Early versus standard closure of temporary ileostomy in patients with rectal cancer: A randomized controlled trial. J Surg Oncol. 2019 Aug;120(2):294-299. doi: 10.1002/jso.25488. (IF=2,886)
  3. Drevinskaite M, Patasius A, Kincius M, Jievaltas M, Smailyte G. A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania. Medicina (Kaunas). 2019 Aug 30;55(9). doi: 10.3390/medicina55090552. (IF=1,467)
  4. Dulskas A, Atkociunas A, Kilius A, Petrulis K, Samalavicius NE. Is Previous Transanal Endoscopic Microsurgery for Early Rectal Cancer a Risk Factor of Worse Outcome following Salvage Surgery A Case-Matched Analysis. Visc Med. 2019 Jun;35(3):151-155. doi: 10.1159/000493281. (IF=1,989)
  5. Dulskas A, Cereska V, Zurauskas E, Stratilatovas E, Jankevicius F. Prostate cancer solitary metastasis to anal canal: case report and review of literature. BMC Cancer. 2019 Apr 23;19(1):374. doi: 10.1186/s12885-019-5573-9. (IF=2,933)
  6. Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer. Aging (Albany NY). 2019 Sep 13;11(17):7197-7205. doi: 10.18632/aging.102245. (IF=5,515)
  7. Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Urbonas V, Smailyte G. Metformin increases cancer specific survival in colorectal cancer patients–National cohort study. Cancer Epidemiol. 2019 Oct;62:101587. doi: 10.1016/j.canep.2019.101587. (IF=2,619)
  8. Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Urbonas V, Smailyte G. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study. Eur J Cancer Prev. 2019 Sep 16. doi: 10.1097/CEJ.0000000000000547. (IF=2,33)
  9. Dulskas A, Patasius A, Kaceniene A, Urbonas V, Smailyte G. Suicide risk among colorectal cancer patients in Lithuania. Int J Colorectal Dis. 2019 Mar;34(3):555-558. doi: 10.1007/s00384-018-03228-4. (IF=2,533)
  10. Dulskas A, Smolskas E, Kildusiene I, Maskelis R, Stratilatovas E, Miliauskas P, Tikuisis R, Samalavicius N. Outcomes of surgical management of iatrogenic colonic perforation by colonoscopy and risk factors for worse outcome. J BUON. 2019 Mar-Apr;24(2):431-435. (IF=1,379)
  11. Bakavicius A, Daniunaite K, Zukauskaite K, Barisiene M, Jarmalaite S, Jankevicius F. Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging. Clin Epigenetics. 2019 Aug 5;11(1):115. doi: 10.1186/s13148-019-0716-z. (IF=5,496)
  12. Elsakov P, Ostapenko V, Luksyte A, Smailyte G. Similar 10-year survival in breast cancer patients of Lithuania and Poland with common BRCA1 founder mutations. Breast Cancer Management, 2019; 8(2): 1-3.
  13. European Society of Coloproctology (ESCP) collaborating group: (collaborator 1102: Dich Grandt S, El-Hussuna A, Dulskas A). Patients with Crohn's disease have longer post-operative in-hospital stay than patients with colon cancer but no difference in complications' rate. World J Gastrointest Surg. 2019 May 27;11(5):261-270. doi: 10.4240/wjgs.v11.i5.261. (IF= 2,686)
  14. Fizazi K, Kappeler C, Snapir A, Sarapohja T, Smith MR, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I. Darolutamide in nonmetastatic, castration-resistant prostate cancer. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. (IF=79,26)
  15. Gedvilaitė V, Danila E, Cicėnas S, Smailytė G. Lung cancer survival in Lithuania: changes by histology, age, and sex from 2003-2007 to 2008-2012. Cancer Control. 2019 Jan-Dec;26(1):1073274819836085. doi: 10.1177/1073274819836085. (IF=2,009)
  16. Harrison EM. GlobalSurg Collaborative: (collaborators 3445: Kuliavas J, Dulskas A, Samalavičius NE). Pooled analysis of WHO Surgical Safety Checklist use andmortality after emergency laparotomy. Br J Surg. 2019 Jan;106(2):e103-e112. doi: 10.1002/bjs.11051. (IF=5,586)
  17. Linkeviciute-Ulinskiene D, Dulskas A, Patasius A, Zabuliene L, Urbonas V, Smailyte G. Response to Letter to the Editor: Metformin in colorectal cancer: A match ruled by MiR26b? Cancer Epidemiol. 2020 Feb;64:101626. doi: 10.1016/j.canep.2019.101626. (IF=2,619)
  18. Liutkevičienė R, Mečėjus G, Žilovič D, Bumbulienė Ž. Endometrial biopsy and density of nerve fibres in eutopic endometrium. Looking for easier ways to diagnose endometriosis. Gynecol Endocrinol. 2019 Dec;35(12):1107-1110. doi: 10.1080/09513590.2019.1640198. (IF=1,406)
  19. Maleckaite R, Zalimas A, Bakavicius A, Jankevicius F, Jarmalaite S, Daniunaite K. DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma. Oncol Rep. 2019 Jun;41(6):3535-3544. doi: 10.3892/or.2019.7109. (IF=3,041)
  20. Milonas D, Venclovas Ž, Gudinaviciene I, Auskalnis S, Zviniene K, Jurkiene N, Basevicius A, Patasius A, Jievaltas M, Joniau S. Impact of the 2014 international society of urological pathology grading system on concept of high-risk prostate cancer: comparison of long-term oncological outcomes in patients undergoing radical prostatectomy. Front Oncol. 2019 Nov 19;9:1272. doi: 10.3389/fonc.2019.01272. (IF=4,137)
  21. Patasius A, Innos K, Barchuk A, Ryzhov A, Leja M, Misins J, Yaumenenka A, Smailyte G. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine. BMJ Open. 2019 Oct 9;9(10):e031856. doi: 10.1136/bmjopen-2019-031856. (IF=2,376)
  22. Patasius A, Kincius M, Kazlauskas E, Smailyte G. The role of androgen-deprivation therapy on suicide among patients with advanced prostate cancer: A nationwide population-based cohort study. Psychooncology. 2019 Oct;28(10):2098-2100. doi: 10.1002/pon.5186. (IF=3,43)
  23. Patasius A, Smailyte G. Changing stage distribution of prostate cancer in a Lithuanian population – evidence from national PSA-based screening programme. Int J Environ Res Public Health. 2019 Dec; 16(23): 4856. doi: 10.3390/ijerph16234856. (IF=2,468)
  24. Patasius A, Urbonas V, Smailyte G. Skin Melanoma and Subsequent Risk of Prostate Cancer: A Lithuanian Cancer Registry Study. Int J Environ Res Public Health. 2019 Oct; 16(20): 3915. doi: 10.3390/ijerph16203915. (IF=2,468)
  25. Steponaviciene L, Vincerzevskiene I, Briediene R, Urbonas V, Vanseviciute-Petkeviciene R, Smailyte G. Breast Cancer Screening Program in Lithuania: Interval Cancers and Program Sensitivity After 7 Years of Mammography Screening. Cancer Control. 2019 Jan-Dec; 26(1): 1073274819874122. doi: 10.1177/1073274819874122. (IF=2,009)


  1. Battersby N, Glasbey JC, Neary P, Negoi I, Kamarajah S, Sgro A, Nepogodiev D, Bhangu A, Pinkney T, Frasson M, Europeanan Society of Coloproctology (ESCP) collaborating group: Venskutonis D, Bradulskis S, Dainius E, Subocius A, Vencius J, Zeromskas P, Eismontas V, Nutautiene V, Simcikas D, Tamosiunas A, Svagzdys S, Latkauskas T, Lizdenis P, Saladzinskas Z, Tamelis A, Dulskas A, Kuliavas J, Samalavicius NE, Poskus, Jotautas V, Mikalauskas S, Poskus E, Strupas K. Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery. Colorectal Dis. 2018 Sep;20 Suppl 6:58-68. doi: 10.1111/codi.14361. (IF=2,997)
  2. Bausys R, Bausys A, Maneikis K, Belogorceva V, Stratilatovas E, Strupas K. Safety of expanded criteria for endoscopic resection of early gastric cancer in a Western cohort. BMC Surg. 2018 Sep 25;18(1):79. doi: 10.1186/s12893-018-0414-3. (IF=1,775)
  3. Bausys R, Bausys A, Stanaitis J, Vysniauskaite I, Maneikis K, Bausys B, Stratilatovas E, Strupas K. Propensity score-matched comparison of short-term and long-term outcomes between endoscopic submucosal dissection and surgery for treatment of early gastric cancer in a Western setting. Surg Endosc. 2019 Oct;33(10):3228-3237. doi: 10.1007/s00464-018-06609-6. (IF=3,209)
  4. Baušys R, Baušys A, Vyšniauskaitė I, Maneikis K, Stratilatovas E, Strupas K. Surgical treatment outcomes of patients with T1-T2 gastric cancer: does the age matter when excellent treatment results are expected? World J Surg Oncol. 2018 Apr 16;16(1):79. doi: 10.1186/s12957-018-1388-4. (IF=1,966)
  5. Coloproctology collaborating group, Jotautas V, Mikalauskas S, Poškus E, Poškus T, Strupas K, Latkauskas T, Lizdenis P, Saladžinskas Ž, Švagždys S, Tamelis A, Razbadauskas A, Sokolovas M, Dulskas A, Samalavičius NE. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection An international audit by ESCP and S-ECCO. Colorectal Dis. 2017 Sep 15. doi: 10.1111/codi.13889. (IF=2,997)
  6. Daniūnaitė K, Jarmalaitė S, Kriukienė E. Epigenomic technologies for deciphering circulating tumor DNA. Curr Opin Biotechnol. 2019 Feb;55:23-29. doi: 10.1016/j.copbio.2018.07.002. (IF=8,083)
  7. Dulskas A, Smolskas E, Kildusiene I, Samalavicius NE. Treatment possibilities for low anterior resection syndrome: a review of the literature. Int J Colorectal Dis. 2018 Mar;33(3):251-260. doi: 10.1007/s00384-017-2954-x. (IF=2,641)
  8. European Society of Coloproctology (ESCP) collaborating group (1371): Sánchez-Guillén L, Bradulskis S, Dainius E, Subočius A, Vencius J, Žeromskas P, Eismontas V, Nutautienė V, Simcikas D, Tamošiūnas A, Švagždys S, Nepogodiev D, Latkauskas T, Lizdenis P, Saladžinskas Ž, Tamelis A, Dulskas A, Kuliavas J, Samalavičius NE, Poškus T, Jotautas V, Mikalauskas S, Sivrikoz E, Poškus E, Strupas K, van Elst T, Minaya A, Pata F, Glasbey J, Pinkney T, Bhangu A, Venskutonis D. Safety of primary anastomosis following emergency left sided colorectal resection: an international, multi‐centre prospective audit. Colorectal Dis. 2018 Sep;20 Suppl 6:47-57. doi: 10.1111/codi.14373. (IF=2,997)
  9. European Society of Coloproctology (ESCP) collaborating groups (1365): Glasbey JC, Venskutonis D, Bradulskis S, Dainius E, Subočius A, Vencius J, Žeromskas P, Eismontas V, Nutautiene V, Simcikas D, Tamošiūnas A, Bhangu A, Švagždys S, Latkauskas T, Lizdenis P, Saladžinskas Ž, Tamelis A, Dulskas A, Kuliavas J, Samalavičius NE, Poškus T, Jotautas V, van der Pool A, Mikalauskas S, Poškus E, Strupas K, Rawlings A, Anchez-Guill en LS, Kuiper S, Negoi I, Buchs N, Nepogodiev D, Pinkney T. The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit. Colorectal Dis. 2018 Sep;20 Suppl 6:69-89. doi: 10.1111/codi.14371. (IF=2,997)   
  10. European Society of Coloproctology (ESCP) collaborating group (1364): Bhangu A, Vencius J, Žeromskas P, Eismontas V, Nutautiene V, Simcikas D, Tamošiūnas A, Švagždys S, Latkauskas T, Lizdenis P, Saladžinskas Ž, Minaya-Bravo AM, Tamelis A, Dulskas A, Kuliavas J, Samalavičius NE, Poškus T, Jotautas V, Mikalauskas S, Poškus E, Strupas K, Gallo G, Glasbey JC, Kamarajah S, Pinkney T, Venskutonis D, Bradulskis S, Dainius E, Subočius A. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME). Colorectal Dis. 2018 Sep;20 Suppl 6:33-46. doi: 10.1111/codi.14376. (IF=2,997)
  11. European Society of Coloproctology (ESCP) collaborating group (1367): Glasbey JC, Vencius J, Žeromskas P, Eismontas V, Nutautienė V, Simcikas D, Tamošiūnas A, Švagždys S, Latkauskas T, Lizdenis P, Saladžinskas Ž, Blanco-Colino R, Tamelis A, Dulskas A, Kuliavas J, Samalavičius NE, Poškus T, Jotautas V, Mikalauskas S, Poškus E, Strupas K, Kelly M, Singh B, Bhangu A, Poškus T, Venskutonis D, Bradulskis S, Dainius E, Subočius A. Association of mechanical bowel preparation with oral antibiotics and anastomotic leak following left sided colorectal resection: an international, multi-centre, prospective audit. Colorectal Dis. 2018 Sep;20 Suppl 6:15-32. doi: 10.1111/codi.14362. (IF=2,997)
  12. GlobalSurg Collaborative* (1816): Harrison EM, Montrimaitė M, Šlapelytė E, Dainius E, Riauka R, Dambrauskas Ž, Subočius A, Venclauskas L, Gulbinas A, Bradulskis S, Kasputytė S, Jokubauskas M, Mikuckytė D, Kiudelis M, Žilinskas J, Jankus T, Petrikėnas S, Pažuskis M, Urniežius Z, Vilčinskas M, Banaitis VJ, Gaižauskas V, Gribauskaitė J, Grišin E, Mazrimas P, Račkauskas R, Drungilas M, Lagunavičius K, Lipnickas V, Majauskytė D, Jotautas V, Abaliksta T, Uščinas L, Venskutonis D, Simutis G, Ladukas A, Danys D, Laugžemys E, Mikalauskas S, Poškus T, Zdanytė Sruogienė E, Višinskas P, Žilinskienė R, Dragatas D, Kuliavas J, Burmistrovas A, Tverskis Ž, Vaičius A, Maželytė R, Zadorožnas A, Kaselis N, Žiubrytė G, Dulskas A, Samalavičius NE, Jasaitis K, Paršeliūnas A, Nevieraitė V. Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study. Lancet Infect Dis. 2018 May;18(5):516-525. doi: 10.1016/S1473-3099(18)30101-4. (IF=27,516)
  13. Kaceniene A, Danila E, Cicenas S, Smailyte G. Suicide risk among lung cancer patients in Lithuania. Clin Respir J. 2018 Sep;12(9):2455-2456. doi: 10.1111/crj.12916. (IF=1,751)
  14. Kišonas J, Venius J, Sevriukova O, Grybauskas M, Guogyte K, Burneckis A, Rotomskis R. Application of reflectance confocal microscopy for early diagnosis of radiation-induced acute dermatitis in radiosensitive patient: case study. Radiat Prot Dosimetry. 2018 Dec 1;182(1):93-97. doi: 10.1093/rpd/ncy135. (IF=0,831)
  15. Kuzmickiene I, Atkocius V, Aleknavicius E, Ostapenko V. Impact of season of diagnosis on mortality among breast cancer survivors. J Cancer Res Ther. 2018 Dec;14(Supplement):S1091-S1097. doi: 10.4103/0973-1482.191064. (IF=1,392)
  16. Lukoseviciene V, Tikuisis R, Dulskas A, Miliauskas P, Ostapenko V. Surgery for triple-negative breast cancer: does the type of anaesthesia have an influence on oxidative stress, inflammation, molecular regulators, and outcomes of disease? J BUON. 2018 Mar-Apr;23(2):290-295. (IF=1,379)
  17. Samalavicius NE, Dulskas A, Uselis S, Smolskas E, Smailyte G, Lunevicius R. High vascular ligation in left-sided colon cancer surgery is safe and adequate. European Surgery. 2018; 50(5): 221-227.DOI: 10.1007/s10353-018-0542-0. (IF=1,629)
  18. Samuolis N, Samalavicius NE, Dulskas A, Markelis R, Lunevicius R, Mickys U, Ringeleviciute U. Surgical or endoscopic management of malignant colon polyps. ANZ J Surg. 2018 Dec;88(12):E824-E828. doi: 10.1111/ans.14846. (IF=1,605)
  19. Stakišaitis D, Juknevičienė M, Ulys A, Žaliūnienė D, Stanislovaitienė D, Šepetienė R, Slavinska A, Sužiedėlis K, Lesauskaitė V. ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. Oncol Lett. 2018 Jul;16(1):1321-1331. doi: 10.3892/ol.2018.8749. (IF=1,871)
  20. Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Kelsch C, Lee A, Coleman S, Deng Y, Shen Y, Kowanetz M, Lopez-Chavez A, Sandler A, Reck M; IMpower150 Study Group Collaborators (307): Cicėnas S. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. N Engl J Med. 2018 Jun 14;378(24):2288-2301. doi: 10.1056/NEJMoa1716948. (IF=70,670)
  21. Skeberdytė A, Sarapinienė I, Aleksander-Krasko J, Stankevičius V, Sužiedėlis K, Jarmalaitė S. Dichloroacetate and salinomycin exert a synergistic cytotoxic effect in colorectal cancer cell lines. Sci Rep. 2018 Dec 10;8(1):17744. doi: 10.1038/s41598-018-35815-4. (IF=4,011)
  22. Urbonas V, Schadendorf D, Zimmer L, Danson S, Marshall E, Corrie P, Wheater M, Plummer E, Mauch C, Scudder C, Goff M, Love SB, Mohammed SB, Middleton MR. Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF Melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial. Ann Oncol. 2019 Feb 1;30(2):317-324. doi: 10.1093/annonc/mdy500. (IF=14,196)
  23. Urbonas V, Smailyte G. Combination of cytokine-directed and anti-programmed cell death protein 1 therapy - a new attractive option in melanoma treatment? Melanoma Res. 2018 Oct;28(5):469-470. doi: 10.1097/CMR.0000000000000470. (IF=2,381)
  24. Writing group and ESCP Cohort Studies and Audits Sub-Committee: J. C. Glasbey, D. Nepogodiev, N. Battersby, A. Bhangu, A. El-Hussuna, M. Frasson, B. Singh, S. Vennix, O. Zmora, T. Pinkney, S. Chaudhri (overall guarantor); 2015 European Society of Coloproctology Collaborating Group (1102): [...]T. Latkauskas, P. Lizdenis, Ž. Saladžinskas, S. Švagždys, A. Tamelis , A. Razbadauskas, M. Sokolovas, A. Dulskas, N. Samalavicius, V. Jotautas, S. Mikalauskas, E. Poskus, T. Poskus, K. Strupas [...]. The impact of stapling technique and surgeon specialism onanastomotic failure after right-sided colorectal resection: aninternational multicentre, prospective audit. Colorectal Dis. 2018 Nov;20(11):1028-1040. doi: 10.1111/codi.14308. (IF=2,997)
  25. Dulskas A, Poskus T, Poskus E, Strupas K. Long-term outcomes after surgery for appendiceal mucinous tumours. Visc Med. 2018 Apr;34(2):151-155. doi: 10.1159/000485092.


  1. Baltruskeviciene E, Kazbariene B, Aleknavicius E, Krikstaponiene A, Venceviciene L, Suziedelis K, Stratilatovas E, Didziapetriene J. Changes of reduced glutathione and glutathione S-transferase levels in colorectal cancer patients undergoing treatment. Tumori. 2018 Oct;104(5):375-380. doi: 10.5301/tj.5000674. (IF=1,233)
  2. Baltruskeviciene E, Schveigert D, Stankevicius V, Mickys U, Zvirblis T, Bublevic J, Suziedelis K, Aleknavicius E. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. BMC Cancer. 2017 Sep 1;17(1):607. doi: 10.1186/s12885-017-3575-z. (IF=3,288)
  3. Bausys R, Bausys A, Vysniauskaite I, Maneikis K, Klimas D, Luksta M, Strupas K, Stratilatovas E. Risk factors for lymph node metastasis in early gastric cancer patients: Report from Eastern Europe country – Lithuania. BMC Surg. 2017 Nov 23;17(1):108. doi: 10.1186/s12893-017-0304-0. (IF=1,422)
  4. Daniunaite K, Dubikaityte M, Gibas P, Bakavicius A, Lazutka JR, Ulys A, Jankevicius F, Jarmalaite S. Clinical significance of miRNA host gene promoter methylation in prostate cancer. Hum Mol Genet. 2017 Jul 1;26(13):2451-2461. doi: 10.1093/hmg/ddx138. (IF=5,340)
  5. Demidenko R, Daniunaite K, Bakavicius A, Sabaliauskaite R, Skeberdyte A, Petroska D, Laurinavicius A, Jankevicius F, Lazutka JR, Jarmalaite S. Decreased expression of MT1E is a potential biomarker of prostate cancer progression. Oncotarget. 2017 Jun 27;8(37):61709-61718. doi: 10.18632/oncotarget.18683. (IF=5,168)
  6. Dulskas A, Kilius A, Petrulis K, Samalavicius NE. Transanal endoscopic microsurgery for giant benign rectal tumours: is large size a contraindication? Int J Colorectal Dis. 2017 Dec;32(12):1759-1761. doi: 10.1007/s00384-017-2910-9. (IF=2,426)
  7. Everatt R, Kuzmickiene I, Davidaviciene E, Cicenas S. Non-pulmonary cancer risk following tuberculosis: a nationwide retrospective cohort study in Lithuania. Infect Agent Cancer. 2017 May 31;12:33. doi: 10.1186/s13027-017-0143-8. (IF=1,422)
  8. Fizazi K, Ulys A, Sengeløv L, Moe M, Ladoire S, Thiery-Vuillemin A, Flechon A, Guida A, Bellmunt J, Climent MA, Chowdhury S, Dumez H, Matouskova M, Penel N, Liutkauskiene S, Stachurski L, Sternberg CN, Baton F, Germann N, Daugaard G. A randomized, double blind, placebo controlled phase 2 study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy. Ann Oncol. 2017 Nov 1;28(11):2741-2746. doi: 10.1093/annonc/mdx487. (IF=11,855)
  9. Gyvyte U, Juzenas S, Salteniene V, Kupcinskas J, Poskiene L, Kucinskas L, Jarmalaite S, Stuopelyte K, Hemmrich-Stanisak G, Hübenthal M, Franke A, Pangonyte D, Lesauskaite V, Kupcinskas L, Skieceviciene J. MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencing. Oncotarget. 2017 Jun 6;8(23):37225-37238. doi: 10.18632/oncotarget.16664. (IF=5,168)
  10. Han YD, Al Bandar MH, Dulskas A, Cho MS, Hur H, Min BS, Lee KY, Kim NK. Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis. BMC Surg. 2017 Mar 21;17(1):28. doi: 10.1186/s12893-017-0224-z. (IF=1,469)
  11. Jagelavicius Z, Jovaisas V, Mataciunas M, Samalavicius NE, Janilionis R. Preoperative predictors of conversion in thoracoscopic surgery for pleural empyema. Eur J Cardiothorac Surg. 2017 Jul 1;52(1):70-75. doi: 10.1093/ejcts/ezx054. (IF=3,759)
  12. Kazakeviciute-Januskeviciene G, Usinskas A, Januskevicius E, Usinskiene J, Letautiene S. Annotation of the medical images using quick response codes. Computer science and information systems. 2017; 14(1):175–196. (IF=0,837)
  13. Kettunen E, Hernandez-Vargas H, Cros MP, Durand G, Le Calvez-Kelm F, Stuopelytė K, Jarmalaitė S, Salmenkivi K, Anttila S, Wolff H, Herceg Z, Husgafvel-Pursiainen K. Asbestos-associated genome-wide DNA methylation changes in lung cancer. Int J Cancer. 2017 Nov 15;141(10):2014-2029. doi: 10.1002/ijc.30897. (IF=6,513)
  14. Pautier P, Vergote I, Joly F, Melichar B, Kutarska E, Hall G, Lisyanskaya A, Reed N, Oaknin A, Ostapenko V, Zvirbule Z, Chetaille E, Geniaux A, Shoaib M, Green JA. A phase 2, randomized, open-label study of irosustat versus megestrol acetate in advanced endometrial cancer. Int J Gynecol Cancer. 2017 Feb;27(2):258-266. doi: 10.1097/IGC.0000000000000862. (IF=2,369)
  15. Samalavicius NE, Dulskas A, Aliukonis V, Rackauskas R, Kilius A. Hybrid transanal and laparoscopic hand-assisted total mesorectal excision for low rectal cancer. ANZ J Surg. 2017 Nov;87(11):953-954. doi: 10.1111/ans.13838. (IF=1,513)
  16. Stankevicius V, Kunigenas L, Stankunas E, Kuodyte K, Strainiene E, Cicenas J, Samalavicius NE, Suziedelis K. The expression of cancer stem cell markers in human colorectal carcinoma cells in a microenvironment dependent manner. Biochem Biophys Res Commun. 2017 Mar 18;484(4):726-733. doi: 10.1016/j.bbrc.2017.01.111. (IF=2,466)
  17. Stankevicius V, Vasauskas G, Rynkeviciene R, Venius J, Pasukoniene V, Aleknavicius E, Suziedelis K. Microenvironment and Dose-Delivery-Dependent Response after Exposure to Ionizing Radiation in Human Colorectal Cancer Cell Lines. Radiat Res. 2017 Sep;188(3):291-302. doi: 10.1667/RR14658.1. (IF=2,539)


  1. Baltruškevičienė E, Kazbarienė B, Badaras R, Bagdonaitė L, Krikštaponienė A, Zdanavičius L, Aleknavičius E, Didžiapetrienė J. Glutathione and glutathione S-transferase levels in patients with liver metastases of colorectal cancer and other hepatic disorders. Turk J Gastroenterol. 2016 Jul;27(4):336-41. doi: 10.5152/tjg.2016.15457. (IF=0,532)
  2. Cicenas S, Geater SL, Petrov P, Hotko Y, Hooper G, Xia F, Mudie N, Wu YL. Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study). Lung Cancer. 2016 Dec;102:30-37. doi: 10.1016/j.lungcan.2016.10.007. (IF=3,767)
  3. Dulskas A, Klivickas A, Kilius A, Samalavicius NE, Sumauskas R, Markelis R. Multiple malignant inflammatory myofibroblastic tumors of the jejunum: A case report and literature review. Oncol Lett. 2016 Feb;11(2):1586-1588. DOI:10.3892/ol.2015.4060. (IF=1,482)
  4. Dulskas A, Miliauskas P, Tikuisis R, Escalante R, Samalavicius NE. The functional results of radical rectal cancer surgery: review of the literature. Acta Chir Belg. 2016 Feb;116(1):1-10. doi: 10.1080/00015458.2015.1136482. (IF=0,394)
  5. Dulskas A, Samalavicius NE. A prospective study of sexual and urinary function before and after total mesorectal excision. Int J Colorectal Dis. 2016 Jun;31(6):1125-30. doi: 10.1007/s00384-016-2549-y. (IF=2,383)
  6. Everatt R, Kuzmickiene I, Davidaviciene E, Cicenas S. Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania. Int J Tuberc Lung Dis. 2016 Jun;20(6):757-63. doi: 10.5588/ijtld.15.0783. (IF=2,148)
  7. Samalavicius NE, Dulskas A, Lasinskas M, Smailyte G. Validity and reliability of a Lithuanian version of low anterior resection syndrome score. Tech Coloproctol. 2016 Apr;20(4):215-20. doi: 10.1007/s10151-015-1424-0. (IF=2,320)
  8. Samalavicius NE, Smolskas E, Mikelis K, Samalavicius R. Transanal endoscopic microsurgery for rectal adenomas: single center experience. Wideochir Inne Tech Maloinwazyjne. 2016;11(1):26-30. doi: 10.5114/wiitm.2015.56408. (IF=0,920)
  9. Schveigert D, Krasauskas A, Didžiapetrienė J, Kalibatienė D, Cicėnas S. Smoking, hormonal factors and molecular markers in female lung cancer. Neoplasma. 2016;63(4):504-9. doi: 10.4149/neo_2016_402. (IF=1,961)
  10. Stakisaitis D, Lesauskaitė V, Girdauskaitė M, Janulionis E, Ulys A, Benetis R. Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a Review. Int J Endocrinol. 2016;2016:8347379. doi: 10.1155/2016/8347379. (IF=2,376)
  11. Tikuisis R, Miliauskas P, Lukoseviciene V, Samalavicius N, Dulskas A, Zabuliene L, Zabulis V, Urboniene J. Transversus abdominis plane block for postoperative pain relief after hand-assisted laparoscopic colon surgery: a randomized, placebo-controlled clinical trial. Tech Coloproctol. 2016 Dec;20(12):835-844. (IF=2,320)
  12. Ulinskas K, Janulionis E, Valuckas KP, Samerdokiene V, Atkocius V, Rivard MJ. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR 252Cf or HDR 60Co intracavitary brachytherapy. Brachytherapy. 2016 May-Jun;15(3):353-360. doi: 10.1016/j.brachy.2016.02.004. (IF=2,088)
  13. Ulyte A, Katsaros VK, Liouta E, Stranjalis G, Boskos C, Papanikolaou N, Usinskiene J, Bisdas S. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients. Neuroradiology. 2016 Dec;58(12):1197-1208. DOI:10.1007/s00234-016-1741-7. (IF=2,274)
  14. Usinskiene J, Ulyte A, Bjornerud A, Venius J, Katsaros VK, Rynkeviciene R, Letautiene S, Norkus D, Suziedelis K, Rocka S, Usinskas A, Aleknavicius E. Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics. Neuroradiology. 2016 Apr;58(4):339-50. doi: 10.1007/s00234-016-1642-9. (IF=2,274)
  15. Samalavicius NE, Dulskas A, Baltruskeviciene E, Smailyte G, Skuciene M, Mikelenaite R, Venslovaite R, Aleknavicius E, Samalavicius A, Lunevicius R. Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not? Wideochir Inne Tech Maloinwazyjne. 2016;11(4):274-282. doi: 10.5114/wiitm.2016.64981.

Updated 2020-02-25 10:40